ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Herantis Pharma to develop non-invasive CDNF for Parkinson’s
pharmaceutical-technology
July 12, 2018Finnish drug development firm Herantis Pharma has launched a new programme for the development of a non-invasive cerebral dopamine neurotrophic factor (CDNF) to treat patients with Parkinson’s disease. -
Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema
firstwordpharma
April 17, 2018Herantis pharmaceuticals today announced the positive results from the 1 phase of clinical research. -
Herantis Pharma Plc publishes introductory video on its Lymfactin with the leading lymphedema advoca
firstwordpharma
January 24, 2017Herantis Pharma Plc ("Herantis") has published an introductory video explaining the mechanism of its innovative drug candidate Lymfactin?, which it develops as a disease modifying treatment for lymphedema.
Pharma Sources Insight January 2025
